Hemodynamic Monitoring
Vasospasm (e.g., Subarachnoid Hemorrhage)
Key Facts
About NeuraSignal
NeuraSignal is a commercial-stage medical device company revolutionizing neurovascular monitoring through its autonomous, robotic TCD ultrasound platform. Its flagship NG2 system leverages AI and robotics to automate the technically challenging process of obtaining cerebral blood flow signals, aiming to improve diagnostic accuracy, standardization, and accessibility of TCD exams. The company is initially focused on the stroke care market, with strong clinical evidence demonstrating superior patent foramen ovale (PFO) detection rates compared to traditional echocardiography. By providing real-time, bedside hemodynamic data, NeuraSignal seeks to improve clinical decision-making, reduce hospital costs, and enhance patient outcomes in neurology and critical care.
View full company profile